European Medical Device Technology regularly produces free Webcasts on a wide variety of topics important to medical device professionals. Check back soon for additions to our Webcast schedule.
At the end of January 2012, the European Commission published MEDDEV 2.1/6. This document is designed to provide a frame of reference for stand-alone software under the three medical device directives, which is important for compliance purposes. Many companies coming from a software background are new to medical device regulations and lack the tools for compliance. Since software that assists a medical device in its function also is regulated as a medical device, an understanding of medical device regulation is critical for vendors of software used in clinical settings. In this webcast, Erik Vollebregt, a Dutch lawyer specialised in EU legal matters related to medical devices, will discuss in detail the regulatory issues surrounding stand-alone software and explain how MEDDEV 2.1/6 helps manufacturers achieve compliance and where it may fall short. Attendees will come away from the one-hour session with a clear understanding of compliance as it relates to stand-alone software from a legal perspective.
Erik Vollebregt is a founding partner of Amsterdam-based Axon Lawyers, a boutique law firm that focuses entirely on the life sciences industry. He is specialised in legal, regulatory and IP issues involving the life sciences with a focus in biotechnology and medical devices. He also maintains the medicaldeviceslegal.com blog.
The one-hour webcast will include a question and answer session and will be moderated by Norbert Sparrow, Editor in Chief, EMDT and medtechinsider. Register now!
This pay-per-view webcast will take place on Tuesday, 24 April at 14:00 London/15:00 Paris.
Attendance is €99 per person.
*Please note: Credit card charges will appear in US dollars.
Group rates are also available.
Contact Joyce Gilmore for information: email@example.com, +1 781 869 7976.
Coatings have been utilized in the medical device industry to modify surfaces for over 30 years. Reasons for such coatings include enhancement of electrical and frictional properties, provision of chemical and moisture barrier properties, improvement of the hygienic properties of the surface, and sometimes simple enhancement of the cosmetic perception of a product. Coatings may also be used to facilitate the application of other coatings (a primer or tielayer role) and to control the extraction or release rates of compounds from within or on substrate materials.
The webinar will review the variants of Parylene, their unique and highly useful attributes, their application processes and examples of how Parylenes have solved device performance and materials challenges.
Parylenes are solvent, catalyst and plasticizer-free organic coatings that have an impressive array of attributes. These attributes include:
Parylenes are biostable and biocompatible, having passed an array of ISO 10993 and USP Class VI biological evaluations, documentation of which can be found in FDA Drug and Device Master Files.
Date: 3 May, 2012
Time: 9:00 a.m. ET/14:00 London/15:00 Paris
Duration: 60 minutes
The following webcasts are available on demand for free. Follow the links to register.
Conformal coatings have been used in the medical device, electronics, automotive, military and aerospace industries for many years for a variety of surface modification purposes, including:
As devices and components become smaller and increasingly complex, they present unique challenges for many conformal coatings. Poly (para-xylylene), better known as Parylene, is an ultra-thin, inert, transparent coating that meets these challenges. Parylene provides highly useful dielectric and barrier properties per unit thickness, as well as extreme chemical inertness and freedom from pinholes. The coating is also biocompatible and has passed an array of biological evaluations. Parylene protects components and devices, including stents, pacemakers, cochlear and ocular implants, circuit card assemblies, MEMS, sensors, LEDs, cores, seals and lab-on-a-chip devices, to name only a few.
Parylene deposition takes place in an evacuated, room temperature chamber via a process known as vapor deposition polymerization (VDP). Sometimes also identified as CVD, this process involves the spontaneous polymerization of a conformal polymeric coating onto all exposed substrate surfaces, edges, and into crevices at a predictable rate, with thickness controllable from 500 angstroms to 75 microns.
This webinar will focus on the Parylene's unique properties, how the coating is applied, examples of applications that benefit from Parylene's properties, and advances that have been made in adhesion technologies. As materials and applications continue to advance, Parylene coatings are increasingly used to enhance the reliability of today's, and tomorrow's, innovative technologies.
Originally Broadcast: 1 December, 2011
Duration: 60 minutes
Join Knobbe Martens Olson & Bear LLP Partner, Jerry L. Hefner, Ph.D., J.D., for a discussion around this hot topic and learn how to protect your technology. Until recently, it was commonly believed that there was little value in obtaining IP rights in China. The expense of obtaining and maintaining patents and patent applications in China combined with the lack of an effective means for enforcement, made Chinese IP generally an unattractive investment. Over the last decade, however, China has made significant advancements in providing applicants with reasonably cost effective means for both securing and enforcing IP rights. In view of China's new found wealth and glut of well-trained scientists and engineers, any innovator would be remiss not to include China as part of its IP strategy.
In this seminar you will learn the types of IP protection that the Chinese system has to offer as well as cost effective approaches that non-Chinese entities can employ to reduce the likelihood of unauthorized exploitation of their technologies in China. In addition, you will learn how to control infringing activities through enforcement actions as well as realistic expectations for enforcement outcomes in China.
Originally Broadcast: December 6, 2011
Duration: 60 minutes
Group rates are also available. Contact Sue Johnson for information: firstname.lastname@example.org, (303) 254-4763.
The future of healthcare is wearable, digital and wireless. Hence, the need for miniaturisation of medical devices is growing. In addition to performance, the critical requirements are minimal power consumption and minimal size. During this webcast, industry experts from nano-electronics research center imec and semiconductor provider Texas Instruments (TI) will describe how emerging technologies are helping to make electronic devices smaller while increasing performance and improving energy efficiency. Join us live 14th September and learn how the trend towards miniaturisation is making its way into the consumer medical and home healthcare market, where portability and wearability of devices as well as battery life are key.
Available now for on-demand viewing
Webcast available now – view today: The editors of MD+DI, Medical Product Manufacturing News, European Medical Device Technology, and IVD Technology hosted a panel discussion on "Innovations in Global Healthcare" at MD&M East in New York to address current industry topics and answer questions in front of key industry players. A panel of industry experts fielded questions from our editors and participated in a live Q&A with the audience at the show. Topics of discussion covered global issues such as: Innovation, Healthcare Reform, Comparative Effectiveness, Changes at FDA, Convergent and Emerging Technologies, and more! Now you have the opportunity to watch the Innovations in Healthcare panel in its entirety. Register for this free event.
Available now for on-demand viewing